1. Home
  2. REBN vs CVKD Comparison

REBN vs CVKD Comparison

Compare REBN & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REBN
  • CVKD
  • Stock Information
  • Founded
  • REBN 2015
  • CVKD 2022
  • Country
  • REBN United States
  • CVKD United States
  • Employees
  • REBN N/A
  • CVKD N/A
  • Industry
  • REBN Restaurants
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • REBN Consumer Discretionary
  • CVKD Health Care
  • Exchange
  • REBN Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • REBN 13.1M
  • CVKD 8.2M
  • IPO Year
  • REBN 2022
  • CVKD 2023
  • Fundamental
  • Price
  • REBN $5.05
  • CVKD $0.43
  • Analyst Decision
  • REBN Strong Buy
  • CVKD Strong Buy
  • Analyst Count
  • REBN 1
  • CVKD 2
  • Target Price
  • REBN $16.00
  • CVKD $3.50
  • AVG Volume (30 Days)
  • REBN 51.1K
  • CVKD 70.5K
  • Earning Date
  • REBN 07-19-2024
  • CVKD 08-12-2024
  • Dividend Yield
  • REBN N/A
  • CVKD N/A
  • EPS Growth
  • REBN N/A
  • CVKD N/A
  • EPS
  • REBN N/A
  • CVKD N/A
  • Revenue
  • REBN $5,903,880.00
  • CVKD N/A
  • Revenue This Year
  • REBN $185.18
  • CVKD N/A
  • Revenue Next Year
  • REBN $64.55
  • CVKD N/A
  • P/E Ratio
  • REBN N/A
  • CVKD N/A
  • Revenue Growth
  • REBN 63.56
  • CVKD N/A
  • 52 Week Low
  • REBN $0.92
  • CVKD $0.36
  • 52 Week High
  • REBN $8.80
  • CVKD $2.17
  • Technical
  • Relative Strength Index (RSI)
  • REBN 41.21
  • CVKD 51.24
  • Support Level
  • REBN $4.58
  • CVKD $0.43
  • Resistance Level
  • REBN $5.89
  • CVKD $0.47
  • Average True Range (ATR)
  • REBN 0.63
  • CVKD 0.02
  • MACD
  • REBN -0.21
  • CVKD -0.00
  • Stochastic Oscillator
  • REBN 13.37
  • CVKD 60.00

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an innovative company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Share on Social Networks: